Article · 16 Sep 2026
Conference abstract
Delivery of nanoformulated antiretroviral drugs across the blood brain barrier
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
In HIV management, eradication of virus by sanctuary sites remains a main challenge. In fact, although current antiretroviral (ARV) therapies suppress plasma HIV below detectable levels in a consistent proportion of subjects, total virus eradication is still beyond our possibilities. An important barrier to achieve such goal is related to the suboptimal concentrations of ARVs within the HIV sanctuaries. The central nervous system (CNS) is a key example of sanctuary where viral replication occurs despite of a complete viral suppression in the peripheral blood. In recent years, nanotechnology has provided great promise in the eradication of HIV from CNS. However, this is the first time in which a complex and heavy peptide like enfuvirtide (Enf), which normally does not penetrate in the CNS, is found to cross the blood brain barrier (BBB) of mice, by conjugation with a nanoconstruct. We demonstrated that iron oxide nanoparticles coated with an amphiphilic polimer (MYTS), labeled with FITC, increased AF660-Enf translocation across BBB in vitro, using a validated BBB model composed of rat BMVECs and astrocytes, and in mice i.v. injected with the nanoformulated Enf. We describe a delivery mechanism involving the uptake of MYTS-Enf in the endothelial cells, the nanocomplex dissociation and the release of the peptide, which is efficiently excreted into the outside environment (Figure 1). The dissociation seems to involve the degradation of the PMA shells bearing the peptide into the more mature endosomal compartments, as an effect of the increased acidity and enzymatic activity of their inner environment, to be then completed within lysosomes.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Pharmaceutica Analytica Acta.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutica Analytica Acta
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Luisa Fiandra”
- BylineArticles whose byline prints “Miriam Colombo”
- BylineArticles whose byline prints “Serena Mazzucchelli”
- BylineArticles whose byline prints “Marta Truffi”
- BylineArticles whose byline prints “Davide Prosperi”
- BylineArticles whose byline prints “Fabio Corsi”
